Skip to main content
Home / Current Medicinal Chemistry, Volume 11, Number 14
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 14, 2004

Book review

Preface [Hot Topic: β-Lactams: Synthesis, Stereochemistry, Synthons and Biological Evaluation (Guest Editor: Bimal K. Banik)]
pp. i-i(1)
Author: Banik, Bimal K.

Favourites:
ADD

Review article

Strategies for the Stereocontrolled Formation of Oxygen Analogues of Penicillins and Cephalosporins
pp. 1813-1835(23)
Authors: Lysek, Robert; Borsuk, Katarzyna; Furman, Bartlomiej; Kaluza, Zbigniew; Kazimierski, Arkadiusz; Chmielewski, Marek

Favourites:
ADD

Asymmetric Synthesis of β-Lactams Through the Staudinger Reaction and Their Use as Building Blocks of Natural and Nonnatural Products
pp. 1837-1872(36)
Authors: Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M.

Favourites:
ADD

β-Lactam Cholesterol Absorption Inhibitors
pp. 1873-1887(15)
Author: Burnett, Duane A.

Favourites:
ADD

Azetidin-2-ones, Synthon for Biologically Important Compounds†
pp. 1889-1920(32)
Authors: Deshmukh, A.R. A.S.; Bhawal, B. M.; Krishnaswamy, D.; Govande, Vidyesh V.; Shinkre, Bidhan A.; Jayanthi, A.

Favourites:
ADD

β-Lactams as Versatile Synthetic Intermediates for the Preparation of Heterocycles of Biological Interest
pp. 1921-1949(29)
Authors: Alcaide, Benito; Almendros, Pedro

Favourites:
ADD

The Discovery and Development of Modified Penicillin- and Cephalosporin- Derived β-Lactamase Inhibitors
pp. 1951-1964(14)
Author: Buynak, John D.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content